Alembic Pharma shares rise 4% on receiving USFDA EIR for Vadodara facility
The USFDA conducted the inspection at Alembic Pharmaceuticals' Bioequivalence Facility in Vadodara from March 3 to March 7, 2025. The company had earlier informed the stock exchanges about the completion of the inspection.
\